Sponsor

PDC line pharma

France 29 Avenue Des Maquis Du Gresivaudan, Bp 35, 38701 La Tronche, France

About the sponsor

PDC line pharma focuses on clinical research in non-small-cell lung cancer, with interest in vaccine-based approaches for patients across different treatment settings.

Cancer immunotherapy
Therapeutic cancer vaccines
Anti-tumour immune response

The sponsor’s research activity includes evaluation of immunogenicity and early clinical activity in lung cancer care.

About Specializations

PDC line pharma runs clinical trials in conditions such as Non-small cell lung cancer, among others.

Non-small cell lung cancer

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of PDC*lung01 Vaccine with Pemetrexed or Pembrolizumab for Patients with Non-Small Cell Lung Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:PDC line pharma

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →